Seyedkazemi Setareh

Seyedkazemi Setareh is listed in filings as CHIEF DEVELOPMENT OFFICER at Adverum Biotechnologies, Inc.. This profile follows SEC Form 4 activity through Dec 10, 2025, including sale activity. Recent filings connect the profile to Adverum Biotechnologies, Inc. (ADVM). The current snapshot covers public activity from Aug 6, 2024 to Dec 10, 2025. Reported amounts are shown as $314.5K to $204.8K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.